Advanced prostate cancer can be predicted by PSA level measured up to 25 years earlier
This article has no abstract so we have provided the first paragraph of the full text.
Lilja and colleagues previously reported that serum PSA level in men aged 
50 years was a strong predictor of prostate cancer diagnosed up to 25 years afterwards. However, the researchers concede that many prostate cancers do not cause morbidity or mortality and have, therefore, reanalyzed their data using locally advanced or metastatic disease at diagnosis as the clinical end point.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.